The present paper describes the setup of the microfluidic bead-based immunoassay and demonstrates the performance of the μFBI by analyzing the expression of receptor tyrosine kinases in lysates from breast cancer and normal tissue. The gene discussed is NTRK1; the disease is breast cancer.